Welcome to Multibagg AI
Log in to access personalized features
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Bearish
2
Neutral
6
Bullish
6
Bearish
7
Neutral
6
Bullish
33
Bearish
5
Neutral
0
Bullish
27
Discovery themes featuring this stock
Evexia Lifecare Limited is engaged in the manufacturing and production of edible oils, agricultural products, and the trading of chemicals. It was originally involved in petrochemical downstream production.
The company operates a processing plant in Tundav, Gujarat, classified as a mini-refinery for processing crude oil and hydrocarbons into various products for industrial applications.
Despite previously planned fundraising initiatives, current market conditions have delayed these efforts, indicating potential future capital strategies based on market recovery.
Evexia's product portfolio includes specialty oils and petrochemical products used across automotive and heavy equipment industries.
The firm maintains multiple subsidiaries, reflecting its diversified interest across energy, information technology, and food production sectors.
Chemicals & Petrochemicals
Trading - Chemicals
319 Cr
Low Risk
154.2
42.3
1.6
0.6
2.69
0.47
Sales CAGR
Profit CAGR
ROE
ROCE
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
238.50 | 439 Cr | 26.58 | 3.37 | 2.92 | 12.67 | 17.03 | 7.07 | ||
8.10 | 373 Cr | 62.20 | 6.89 | 0.00 | 11.08 | 10.16 | 5.69 | ||
161.00 | 328 Cr | 24.17 | 1.98 | 0.00 | 8.18 | 11.35 | 5.80 | ||
1.70 | 319 Cr | 154.18 | 0.59 | 0.00 | 0.25 | 0.13 | 0.11 | ||
30.95 | 291 Cr | 34.01 | 4.74 | 0.00 | 13.99 | 18.45 | 0.00 | ||
124.00 | 287 Cr | 3.69 | 0.70 | 0.00 | 18.95 | 12.76 | 5.25 | ||
40.65 | 252 Cr | 18.69 | 2.05 | 0.00 | 10.99 | 13.04 | 8.62 | ||
| Median: 7 Co. | — | 40.65 | 319 Cr | 26.58 | 2.05 | 0.00 | 11.08 | 12.76 | 5.69 |
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Evexia Lifecare Ltd (EVEXIA) is currently trading at 1.75 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Evexia Lifecare Limited is engaged in the manufacturing and production of edible oils, agricultural products, and the trading of chemicals. It was originally involved in petrochemical downstream production. The company operates a processing plant in Tundav, Gujarat, classified as a mini-refinery for processing crude oil and hydrocarbons into various products for industrial applications. Despite previously planned fundraising initiatives, current market conditions have delayed these efforts, indicating potential future capital strategies based on market recovery. Evexia's product portfolio includes specialty oils and petrochemical products used across automotive and heavy equipment industries. The firm maintains multiple subsidiaries, reflecting its diversified interest across energy, information technology, and food production sectors.
Over the past 52 weeks, Evexia Lifecare Ltd has traded between a low of ₹0.47 and a high of ₹2.69. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Evexia Lifecare Ltd has a market capitalization of approximately 319.15. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Evexia Lifecare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 154.18 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 319.15 Cr, Evexia Lifecare Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Evexia Lifecare Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Evexia Lifecare Ltd is 154.18. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
The most significant announcements are the support schemes for MSMEs, including a ₹10,000 crore SME Growth Fund and measures to improve liquidity through the TReDS platform, which could benefit a microcap company like Evexia.
Stake acquisition
Zeal Global Opportunities Fund FCCB disclosed acquisition of 58,002,545 shares (≈3.09% of capital) in Evexia Lifecare Ltd between 01‑06‑2026 and 08‑06‑2026; post-transaction holding reported as 8,98,08,284 shares (≈4.78%) of total capital (eq. capital 1,87,73,28,995).
Shareholding change
Zeal Global Opportunities Fund FCCB sold 5,80,02,545 shares (3.09% of equity) in Evexia Lifecare between 01-06-2026 and 08-06-2026, lowering its holding from 14,78,10,829 (7.87%) to 8,98,08,284 (4.78%) of total equity (1,87,73,28,995).
Substantial acquisition disclosure
09-Jun-2026: Disclosure under Reg.29(2) – Kiran Kumar Jain M acquired 9,500,000 shares of Evexia Lifecare (BSE:524444), raising his stake from 4.62% to 5.12%; no encumbrances or convertible instruments reported.
Substantial Acquisition
Kiran Kumar Jain M disclosed an open‑market acquisition of 7,77,06,376 shares (4.139%) of M/s Evexia Lifecare Ltd on 05‑06‑2026, increasing holding from NIL to 4.139%; company equity ~Rs.187.73 crore.
Substantial Acquisition
Kiran Kumar Jain M disclosed on 05-06-2026 an open-market acquisition of 7,77,06,376 shares (4.139% of voting capital) in Evexia Lifecare Ltd; prior holding was nil.
